Search Results 201-210 of 18523 for Relapse
Relapsed, refractory follicular lymphoma; Relapsed, refractory multiple myeloma; Other types of cancer and medical conditions undergoing clinical studies. If ...
ROCHESTER, Minn. — Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T-cell therapy, ...
About this study. This phase II trial studies how well sapanisertib works in treating patients with acute lymphoblastic leukemia that has returned after a ...
Clinical Trials · First-in-Human Study of FLX925 in Subjects with Relapsed or Refractory Acute Myeloid Leukemia · More about research at Mayo Clinic · Mayo Clinic ...
The purpose of Phase I of this study is to evaluate the safety and tolerability of CTX-712 in patients with relapsed/refractory (R/R) acute myeloid leukemia ( ...
Primaquine is used to treat malaria and prevents it from coming back after treatment (relapse). Primaquine belongs to a group of medicines, called ...
The purpose of this study is to determine adverse events and change in disease symptoms of ABBV-383 in adult participants with relapsed/refractory (R/R) MM.
A potential complication of Hodgkin lymphoma is that the cancer may come back after treatment. This is called a relapse. Relapse is more common in people with ...
The purpose of this study is to determine how well SNS01-T is tolerated by relapsed or refractory multiple myeloma, B cell lymphoma or plasma cell leukemia ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.